# Genesis Biologics, Inc. – FDA Inspection, Sep 16, 2026

Source: https://www.keypedia.com/records/fda_inspections/genesis-biologics-inc/216fe61f-5240-4f29-87bf-c510796efc26
Source feed: FDA_Inspections

> FDA inspection 1336164 of Genesis Biologics, Inc., September 16, 2026. 3 citations under 21 CFR part 803. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1336164
- Company Name: Genesis Biologics, Inc.
- Inspection Date: 2026-09-16
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1293426 - 2025-11-20
- [FDA Inspection 1210563 - 2023-07-21](https://www.keypedia.com/records/fda_inspections/genesis-biologics-inc/cad5c3d5-5b00-4369-aa61-20861c1cec17)
- FDA Inspection 1060113 - 2018-06-26
- FDA Inspection 908700 - 2014-12-10
- [FDA Inspection 783686 - 2012-05-25](https://www.keypedia.com/records/fda_inspections/genesis-biologics-inc/fb7336e1-eca4-42af-a20a-bc2b5b506f89)

## Related Officers

- [Emily S. McGann](https://www.keypedia.com/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)
- [Company Rep](https://www.keypedia.com/people/kaarin-m-slotte/2960bbe1-17ba-4295-9aa8-2514a1595336)

Company: https://www.keypedia.com/companies/genesis-biologics-inc/84455bb8-eb9c-43f1-a6ad-9f154f674d78

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b